letter
editor
potenti
inhibitor
coronaviru
proteas
clinic
approv
medicin
coronavirus
member
famili
coronavirida
subfamili
coronavirina
envelop
positivestrand
rna
virus
spike
glycoprotein
project
viral
envelop
thu
exhibit
corona
halolik
appear
master
perlman
cui
et
al
coronavirus
causal
pathogen
wide
spectrum
respiratori
gastrointestin
diseas
wild
domest
anim
includ
bird
pig
rodent
etc
dhama
et
al
previou
studi
found
six
strain
coronavirus
capabl
infect
human
includ
four
strain
circul
yearli
caus
common
cold
two
strain
sourc
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
merscov
respect
dhama
et
al
cui
et
al
start
decemb
novel
coronaviru
later
name
n
stand
novel
found
caus
sever
acut
respiratori
sari
symptom
includ
fever
dyspnea
asthenia
pneumonia
among
peopl
wuhan
china
zhu
et
al
lu
et
al
hui
et
al
first
batch
patient
infect
almost
connect
seafood
market
wuhan
also
trade
wild
anim
later
contact
transmiss
among
human
confirm
number
infect
patient
increas
rapidli
wuhan
well
major
citi
china
seri
action
taken
chines
govern
control
epidem
viru
effect
medic
method
urgent
need
prevent
infect
cure
diseas
among
known
rna
virus
coronavirus
largest
genom
rang
kb
kb
length
regenmortel
et
al
schoeman
field
besid
encod
structur
protein
major
part
coronaviru
genom
transcrib
translat
polypeptid
encod
protein
essenti
viral
replic
gene
express
lai
holm
aa
long
main
proteas
pro
key
enzym
coronaviru
replic
also
encod
polypeptid
respons
process
polypeptid
function
protein
lai
holm
pro
similar
cleavagesit
specif
picornaviru
proteas
pro
thu
also
known
proteas
pro
gorbalenya
et
al
studi
shown
pro
differ
coronavirus
highli
conserv
term
sequenc
structur
xue
et
al
featur
togeth
function
import
made
pro
attract
target
design
anticoronavir
drug
anand
et
al
xue
et
al
present
still
clinic
approv
antibodi
drug
specif
coronavirus
make
difficult
cure
caus
diseas
control
associ
pandem
hope
identifi
candid
drug
adopt
comput
approach
screen
avail
commerci
medicin
may
function
inhibitor
pro
previou
attempt
predict
drug
pro
sarscov
identifi
two
proteas
inhibitor
name
lopinavir
ritonavir
potenti
candid
bind
target
site
pro
nukoolkarn
et
al
clinic
applic
two
drug
patient
also
appear
effect
demonstr
import
drug
bind
site
suppress
pro
activ
search
drug
may
inhibit
pro
first
evalu
sequenc
structur
conserv
lopinavirritonavir
bind
site
sarscov
protein
sequenc
sarscov
pro
pro
ident
fig
spatial
structur
previous
report
lopinavirritonavir
bind
pocket
also
conserv
sarscov
pro
pro
fig
submiss
process
manuscript
crystal
structur
pro
solv
pdb
id
lopinavirritonavir
bind
pocket
region
nearli
ident
predict
model
fig
conserv
amino
acid
number
accord
posit
sarscov
pro
present
sequenc
pro
genbank
polypeptid
form
form
bind
pocket
lopinavirritonavir
spatial
structur
sarscov
pro
pro
wherea
nearbi
nonconserv
amino
acid
locat
far
away
bind
pocket
thu
would
affect
structur
conserv
fig
virtual
dock
lopinavirritonavir
pro
also
show
high
bind
abil
pocket
site
fig
similar
previou
report
sarscov
pro
nukoolkarn
et
al
amino
acid
predict
key
residu
bind
drug
fig
form
hydrogen
bond
lopinavir
hydrogen
bond
ritonavir
respect
base
result
perform
virtual
dock
screen
commerci
medicin
drugbank
databas
could
bind
mention
pocket
site
pro
identifi
candid
clinic
medicin
tabl
fig
drug
could
form
hydrogen
bond
one
residu
among
therefor
theoret
capabl
bind
pocket
form
amino
acid
interfer
function
pro
summari
base
structur
inform
clinic
effect
medicin
predict
list
j
u
r
n
l
h
p
g
e
w
w
w
j
u
r
n
l
e
l
se
v
e
r
c
j
u
r
n
l
f
g
e
n
e
c
sa
n
g
e
n
c
commerci
medicin
may
function
inhibitor
target
main
proteas
pro
compar
lopinavirritonavir
predict
drug
could
form
hydrogen
bond
pro
thu
may
higher
mutat
toler
lopinavirritonavir
note
result
obtain
sole
silico
predict
experi
need
valid
efficaci
drug
bind
pocket
drug
pro
conserv
sarscov
pro
pro
indic
potenti
drug
inhibitor
coronavirus
similar
pro
bind
site
pocket
structur
